Nafamostat mesilate (FUT-175)

Nafamostat mesilate is a synthetic serine protease inhibitor, used as an anticoagulant during hemodialysis. Nafamostat mesylate blocks activation of SARS-CoV-2 and is investigated as a new treatment option for COVID-19. Nafamostat Mesilate attenuates inflammation and apoptosis.

Price Not Available 10mg Nafamostat mesilate (FUT-175) Supplier Page

Catalog Number	S1386
Molecular Formula	C15H13F6N3O4S2
CAS#	82956-11-4
Inchi	InChI=1S/C15H13F6N3O4S2/c1-7-11(29-12(22-7)23-8(2)25)30(27,28)24-10-5-3-9(4-6-10)13(26,14(16,17)18)15(19,20)21/h3-6,24,26H,1-2H3,(H,22,23,25)
Inchi Key	OZBSSKGBKHOLGA-UHFFFAOYSA-N
SMILES	CC1=C(SC(=N1)NC(=O)C)S(=O)(=O)NC2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O
Size	10mg
Supplier Page	http://www.selleckchem.com/products/Nafamostat-mesylate.html
Additional Information	https://file.selleck.cn/downloads/struct/Nafamostat-mesylate-chemical-structure-S1386.gif